Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
Fragoso YD, Ferreira ML, Morales Nde M, Arruda WO, Brooks JB, Carneiro DS, Carvalho Mde J, Comini-Frota ER, Correa EC, Damasceno CA, Domingues RB, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Grzesiuk AK, Khouri JM, Kaimen-Maciel DR, Mendes MF, Morales Rde R, Ribeiro SB, Ribeiro TA, Albuquerque LB, Anacleto A, Finkelsztejn J, Gama RA, Lopes J, Oliveira CL, Oliveira FT, Pires LA, Saldanha PC, Souza AH, Silva AE. Fragoso YD, et al. Among authors: correa ec. Arq Neuropsiquiatr. 2013 Oct;71(10):783-7. doi: 10.1590/0004-282X20130122. Arq Neuropsiquiatr. 2013. PMID: 24212515 Free article.
Natalizumab adverse events are rare in patients with multiple sclerosis.
Fragoso YD, Alves-Leon SV, Arruda WO, Carvalho Mde J, Comini-Frota ER, Corrêa ÉC, Ferreira ML, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Mendes MF, Morales RR, Muniz A, Salgado PR, Ruocco HH, Albuquerque LB, Brooks JB, Fêzer L, Georgetto S, Lopes J, Malfetano FR, Meira ID, Oliveira CL, Oliveira FT, Safanelli F, Satomi M. Fragoso YD, et al. Among authors: correa ec. Arq Neuropsiquiatr. 2013 Mar;71(3):137-41. doi: 10.1590/s0004-282x2013000300002. Arq Neuropsiquiatr. 2013. PMID: 23563711 Free article.
Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.
Fragoso YD, Adoni T, Almeida SM, Alves-Leon SV, Arruda WO, Barbagelata-Aguero F, Brooks JB, Carra A, Claudino R, Comini-Frota ER, Correa EC, Damasceno A, Damasceno BP, Díaz EC, Elliff DG, Fiore AP, Franco CM, Giacomo MC, Gomes S, Gonçalves MV, Grzesiuk AK, Inojosa JL, Kaimen-Maciel DR, Lin K, Lopes J, Lourenço GA, Martínez AD, Melcon MO, Morales Nde M, Morales RR, Moreira M, Moreira SV, Oliveira CL, Oliveira FT, Ribeiro JB, Ribeiro SB, Rodríguez CC, Russo L, Safanelli J, Shearer KD, Siquineli F, Vizcarra-Escobar D. Fragoso YD, et al. Among authors: correa ec. Arq Neuropsiquiatr. 2013 Sep;71(9A):573-9. doi: 10.1590/0004-282X20130098. Arq Neuropsiquiatr. 2013. PMID: 24141434 Free article.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Barreira AA, Brooks JB, Claudino R, Correa EC, Ferreira ML, Finkelsztejn A, Finkelsztejn J, da Gama PD, Goncalves MV, Guerreiro CT, da Cunha Matta AP, Marques VD, Rizo Morales R, Parolin MF, de Castro Ribeiro M, Ribeiro TA, Ruocco HH, Sato H, Scherpenhuijzen S, Siquineli F, de Carvalho Sousa NA, Varela DL, Tauil CB, Winckler TC. Fragoso YD, et al. Among authors: correa ec. NeuroRehabilitation. 2016 Jun 30;39(2):301-4. doi: 10.3233/NRE-161361. NeuroRehabilitation. 2016. PMID: 27372365
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.
Marques VD, Passos GRD, Mendes MF, Callegaro D, Lana-Peixoto MA, Comini-Frota ER, Vasconcelos CCF, Sato DK, Ferreira MLB, Parolin MKF, Damasceno A, Grzesiuk AK, Muniz A, Matta APDC, Oliveira BES, Tauil CB, Maciel DRK, Diniz DS, Corrêa EC, Coronetti F, Jorge FMH, Sato HK, Gonçalves MVM, Sousa NAC, Nascimento OJM, Gama PDD, Domingues R, Simm RF, Thomaz RB, Morales RR, Dias RM, Apóstolos-Pereira SD, Machado SCN, Junqueira TF, Becker J. Marques VD, et al. Among authors: correa ec. Arq Neuropsiquiatr. 2018 Aug;76(8):539-554. doi: 10.1590/0004-282X20180078. Arq Neuropsiquiatr. 2018. PMID: 30231128 Free article.
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.
Branco LP, Adoni T, Apostolos-Pereira SL, Brooks JBB, Correa EC, Damasceno CA, Eboni ACB, Fezer L, Gama PDD, Goncalves MVM, Gomes S, Grzesiuk AK, Mendes MF, Morales RR, Muniz A, Parolin MFK, Pimentel MLV, Ribeiro MC, Santos GACD, Sato HK, Scherpenhuijzen SB, Scorcine C, Siquineli F, Sousa NAC, Varela DL, Winckler TCA, Fragoso YD. Branco LP, et al. Among authors: correa ec. Arq Neuropsiquiatr. 2018 Sep;76(9):588-591. doi: 10.1590/0004-282X20180083. Arq Neuropsiquiatr. 2018. PMID: 30365621 Free article.
The Brazilian database on pregnancy in multiple sclerosis.
Finkelsztejn A, Fragoso YD, Ferreira ML, Lana-Peixoto MA, Alves-Leon SV, Gomes S, Damasceno BP, Mendes MF, Salgado PR, Correa EC, Comini-Frota ER, Diniz DS, Gama PD, Kaimen-Maciel DR, Morales RR, Arruda WO, Grzesiuk AK, Khouri JM, Lopes JS, Rocha CF, Domingues R, Gonçalves MV, Lorenti MA, Parolin MK, Siquineli F, Tosta ED, Brooks JB, Gallina AS, Melges LD, Ruocco HH. Finkelsztejn A, et al. Among authors: correa ec. Clin Neurol Neurosurg. 2011 May;113(4):277-80. doi: 10.1016/j.clineuro.2010.11.016. Epub 2010 Dec 15. Clin Neurol Neurosurg. 2011. PMID: 21159421
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Fragoso YD, Arruda NM, Arruda WO, Brooks JB, Correa EC, Damasceno A, Damasceno CA, Ferreira ML, Giacomo MC, Gomes S, Gonçalves MV, Grzesiuk AK, Kaimen-Maciel DR, Lopes J, Machado SC, Oliveira CL, Stella CR. Fragoso YD, et al. Among authors: correa ec. Expert Rev Neurother. 2014 Feb;14(2):127-30. doi: 10.1586/14737175.2014.874947. Epub 2014 Jan 13. Expert Rev Neurother. 2014. PMID: 24417188 Review.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Araujo YR, Becker J, Brooks JBB, Correa EC, Damasceno A, Damasceno CAA, Ferreira MLB, Gama PDD, Gama RADD, Gomes S, Goncalves MVM, Grzesiuk AK, Machado SCN, Matta APDC, Mendes MF, Ribeiro TAGJ, Rocha CFD, Ruocco HH, Sato H, Simm RF, Tauil CB, Vasconcelos CCF, Vieira VLF. Fragoso YD, et al. Among authors: correa ec. Expert Rev Clin Pharmacol. 2016 Apr;9(4):541-546. doi: 10.1586/17512433.2016.1145053. Epub 2016 Feb 21. Expert Rev Clin Pharmacol. 2016. PMID: 26794493
47 results